David S. Chervinsky
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 10
- Acute Myeloid Leukemia Research 6
- Chronic Myeloid Leukemia Treatments 5
- Genetics 7
- Chronic Lymphocytic Leukemia Research 5
- Co-authors
- Peter D. AplanMartin StanullaKenneth W. GrossJunjie WangXianfeng ZhaoJeffrey M. RosenJaw J. WangCraig A. Jones
- Journals
- Genes Chromosomes and Cancer (4 papers)Hematological Oncology (3 papers)Molecular and Cellular Biology (2 papers)Cancer (1 paper)Journal of Cellular Physiology (1 paper)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
David S. Chervinsky
26 papers receiving 802 citations
Peers
Comparison fields: 5 of 65
- Hematology 246
- Genetics 107
- Public Health, Environmental and Occupational Health 234
- Oncology 210
- Molecular Biology 496
Countries citing papers authored by David S. Chervinsky
This map shows the geographic impact of David S. Chervinsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Chervinsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Chervinsky more than expected).
Fields of papers citing papers by David S. Chervinsky
This network shows the impact of papers produced by David S. Chervinsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Chervinsky. The network helps show where David S. Chervinsky may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David S. Chervinsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 78 | |
| 2 | 2005 | 30 | |
| 3 | 2003 | 16 | |
| 4 | scid Thymocytes with TCRbeta gene rearrangements are targets for the oncogenic effect of SCL and LMO1 transgenes. | 2001 | 18 |
| 5 | 1999 | 79 | |
| 6 | 1998 | 44 | |
| 7 | 1997 | 59 | |
| 8 | 1997 | 117 | |
| 9 | 1995 | 7 | |
| 10 | Cloning and characterization of TCTA, a gene located at the site of a t(1;3) translocation. | 1995 | 26 |
| 11 | 1995 | 13 | |
| 12 | 1993 | 11 | |
| 13 | 1991 | 8 | |
| 14 | 1989 | 2 | |
| 15 | 1987 | 1 | |
| 16 | 1986 | 1 | |
| 17 | 1986 | 1 | |
| 18 | 1984 | 23 | |
| 19 | 1982 | 44 | |
| 20 | Comparative biochemical studies of adriamycin and daunomycin in leukemic cells. | 1972 | 52 |
About David S. Chervinsky
David S. Chervinsky is a scholar working on Hematology, Genetics, Toxicology, Immunology and Neurology, having authored 28 papers that have together received 838 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (6 papers), Cancer therapeutics and mechanisms (6 papers), Acute Lymphoblastic Leukemia research (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (5 papers), Neuroblastoma Research and Treatments (4 papers), Bioactive Compounds and Antitumor Agents (2 papers) and T-cell and Retrovirus Studies (2 papers). The work is most often cited by research in Hematology (246 citations), Genetics (107 citations), Public Health, Environmental and Occupational Health (234 citations), Oncology (210 citations) and Molecular Biology (496 citations). David S. Chervinsky has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Peter D. Aplan, Martin Stanulla, Kenneth W. Gross, Junjie Wang, Xianfeng Zhao, Jeffrey M. Rosen, Jaw J. Wang, Craig A. Jones, Elizabeth A. McGuire and Cameron K. Tebbi. Their work appears in journals such as Genes Chromosomes and Cancer, Hematological Oncology, Molecular and Cellular Biology, Cancer and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.